Opportunity Information: Apply for CDC RFA GH12 1230
Apply for CDC RFA GH12 1230
- The Centers for Disease Control and Prevention in the health sector is offering a public funding opportunity titled "Building the Institutional Capacity of Local Indigenous Organizations Implementing Comprehensive Clinical and Laboratory Services to Sustain and Enhance the Prevention, Care and Treatment of HIV/AIDS in the Federal Republic of Nigeria under PEPFAR" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.067 Global AIDS.
- This funding opportunity was created on Mar 23, 2012 and posted on Jan 25, 2012.
- Applicants must submit their applications by Apr 4, 2012. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $45,000,000.00 to eligible and selected applicants.
- Each selected applicant is eligible to receive up to $500,000.00 in funding.
- The number of recipients for this funding is limited to 10 candidate(s).
- Eligible applicants include: Small businesses Public and State controlled institutions of higher education City or township governments County governments Others (see text field entitled Additional Information on Eligibility for clarification) For profit organizations other than small businesses Native American tribal governments (Federally recognized) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Special district governments State governments Private institutions of higher education.
- Eligible applicants include Nonprofit with 501C3 IRS status (other than institution of higher education), Nonprofit without 501C3 IRS status (other than institution of higher education), For profit organizations (other than small business), Small, minority, and women owned businesses, Universities, Colleges, Research institutions, Hospitals, Community based organizations, Faith based organizations, Federally recognized or state recognized American Indian/Alaska Native tribal governments, American Indian/Alaska native tribally designated organizations, Alaska Native health corporations, Urban Indian health organizations, Tribal epidemiology centers, State and local governments or their Bona Fide Agents (this includes the District of Columbia, the Commonwealth of Puerto Rico, the Virgin Islands, the Commonwealth of the Northern Marianna Islands, American Samoa, Guam, the Federated States of Micronesia, the Republic of the Marshall Islands, and the Republic of Palau), Political subdivisions of States (in consultation with States), Non domestic (non U.S.) entity. A Bona Fide Agent is an agency/organization identified by the state as eligible to submit an application under the state eligibility in lieu of a state application. If applying as a bona fide agent of a state or local government, a legal, binding agreement from the state or local government as documentation of the status is required. Attach with Other Attachment Forms when submitting via www.grants.gov.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
This CDC cooperative agreement opportunity under PEPFAR focuses on strengthening the long-term ability of local and indigenous Nigerian organizations to run high-quality HIV/AIDS programs, especially those tied to clinical services, laboratory systems, and strategic information. The central goal is sustainability: helping Nigerian organizations build the internal systems, staff skills, governance, and management practices needed to design, implement, monitor, and manage HIV prevention, care, and treatment activities in line with Nigerian national policies and standards. Rather than funding direct service delivery, the program is meant to improve the institutional backbone that allows services to be delivered consistently and effectively over time.
A key point is what the funding does and does not pay for. The announcement makes clear that it will not fund the actual delivery of clinical or laboratory services, and it also will not support related supply chain management activities. In other words, applicants should not propose using these funds to purchase commodities, run clinics, perform tests, or manage procurement and distribution of lab or medical supplies. Instead, the emphasis is on capacity building: strengthening systems such as organizational leadership and governance, program and financial management, quality assurance approaches, monitoring and evaluation, strategic information management, and the skills needed to oversee clinical and laboratory programs that are supported through other mechanisms.
The approach expected from award recipients is hands-on and relationship-driven. Recipients are supposed to work through strategic mentoring relationships with assigned local and indigenous organizations. Over the project period, they are expected to progressively strengthen and institutionalize capacity, meaning improvements should be embedded into standard operating procedures and organizational structures rather than remaining as one-time trainings. This suggests activities like structured mentorship, organizational assessments, development of improvement plans, coaching on compliance with national guidelines, strengthening data systems and reporting practices, and helping organizations build management and oversight capabilities that can survive staff turnover and funding changes.
Logistics and travel support are also spelled out in a specific way. Award recipients are expected to coordinate venues, registration, and travel logistics for capacity-building activities, but this funding opportunity will only pay for travel and accommodations for the award recipient's own staff. Costs for participants from the local/indigenous organizations being supported, such as their travel, lodging, and registration fees, are expected to be covered through other CDC Nigeria-funded award mechanisms. Practically, this means applicants need to design projects that rely on coordination and collaboration with other CDC-supported mechanisms and should budget accordingly, avoiding assumptions that this award will cover broad participant travel or per diem for trainees.
In terms of scale and structure, the opportunity is listed as discretionary funding using a cooperative agreement, which typically means substantial involvement by the CDC in program planning, technical direction, or coordination compared to a standard grant. The funding opportunity number is CDC RFA GH12-1230 under CFDA 93.067 (Global AIDS). The program anticipated up to 10 awards, with an estimated total funding amount of $45,000,000. Individual awards were expected to range from $100,000 (floor) to $500,000 (ceiling). There is no cost-sharing or matching requirement stated, which reduces the burden on applicants to bring additional non-federal funds to the table.
Eligibility is broad and includes a wide mix of U.S. and non-U.S. entities. Eligible applicants include nonprofits with or without 501(c)(3) status, for-profit organizations (including small, minority-, and women-owned businesses), universities and colleges, research institutions, hospitals, community-based and faith-based organizations, tribal governments and tribal health-related entities, and state and local governments or their bona fide agents. The listing also explicitly includes non-domestic (non-U.S.) entities, which is relevant for organizations operating in Nigeria or with Nigerian partners. For applicants applying as a bona fide agent of a state or local government, a binding legal agreement documenting that status is required as part of the application package.
Finally, the timeline shown reflects the original 2012 posting and closeout dates, which matters for context but indicates it is an archived opportunity rather than a currently open competition. It was posted January 25, 2012, with a current closing date of April 4, 2012, and an archive date of May 4, 2012. The administering agency is the Centers for Disease Control and Prevention, with the CDC Procurement and Grants Office listed as a contact point for technical issues accessing the announcement. Overall, the opportunity is best understood as a targeted investment in Nigerian organizational capacity and sustainability for HIV clinical, laboratory, and data systems oversight, not a direct service delivery grant.
Frequently Asked Questions (FAQs)
What is the main purpose of this CDC cooperative agreement opportunity?
The purpose is to strengthen the long-term ability of local and indigenous Nigerian organizations to run high-quality HIV/AIDS programs in a sustainable way. The focus is on building the internal systems, staff skills, governance, and management practices needed to design, implement, monitor, and manage HIV prevention, care, and treatment activities in line with Nigerian national policies and standards.
Is this funding intended to pay for direct HIV clinical or laboratory service delivery?
No. The announcement specifically states it will not fund the actual delivery of clinical services or laboratory services.
Can applicants use these funds to purchase HIV-related commodities or lab/medical supplies?
No. Applicants should not propose using these funds to purchase commodities, run clinics, perform tests, or manage procurement and distribution of lab or medical supplies.
Does this opportunity fund supply chain management activities related to clinical or laboratory services?
No. The funding announcement indicates it will not support supply chain management activities related to clinical or laboratory services.
If it does not fund direct services, what does the program fund instead?
The emphasis is on capacity building and strengthening the institutional backbone that supports consistent, effective service delivery over time. Examples described include strengthening leadership and governance, program and financial management, quality assurance approaches, monitoring and evaluation, strategic information management, and the skills needed to oversee clinical and laboratory programs supported through other mechanisms.
What types of organizations are meant to benefit from this capacity building?
The focus is on local and indigenous Nigerian organizations, with the intent to strengthen their long-term sustainability and ability to manage high-quality HIV/AIDS programs tied to clinical services, laboratory systems, and strategic information.
What approach does CDC expect award recipients to use when providing capacity-building support?
The expected approach is hands-on and relationship-driven, using strategic mentoring relationships with assigned local and indigenous organizations. The goal is to progressively strengthen and institutionalize capacity so improvements are embedded into standard operating procedures and organizational structures rather than remaining as one-time trainings.
What does "institutionalizing capacity" mean in the context of this opportunity?
It means capacity improvements should be built into an organization’s routine systems and structures (for example, through standard operating procedures and strengthened management practices), rather than being limited to one-off trainings or temporary fixes.
What kinds of capacity-building activities are suggested by the opportunity description?
Based on the description, activities can include structured mentorship, organizational assessments, development of improvement plans, coaching on compliance with national guidelines, strengthening data systems and reporting practices, and building management and oversight capabilities that remain effective over time.
How does this opportunity relate to Nigerian national policies and standards?
Supported organizations are expected to develop the ability to design, implement, monitor, and manage HIV prevention, care, and treatment activities in line with Nigerian national policies and standards.
What are the clinical, laboratory, and strategic information areas mentioned in the opportunity?
The opportunity highlights organizational capacity for programs tied to clinical services, laboratory systems, and strategic information. It emphasizes building oversight and management capacity in these areas, not paying for the services themselves.
What are the travel and logistics expectations for award recipients?
Award recipients are expected to coordinate venues, registration, and travel logistics for capacity-building activities. However, this funding opportunity will only pay for travel and accommodations for the award recipient’s own staff.
Will this award pay for travel, lodging, or registration for participants from the supported Nigerian organizations?
No. Costs for participants from the local/indigenous organizations being supported (including travel, lodging, and registration fees) are expected to be covered through other CDC Nigeria-funded award mechanisms.
What does the travel policy imply for project design and budgeting?
Applicants should budget assuming this award covers travel and accommodations only for the recipient’s staff, not for trainees or participants from the supported organizations. It also implies projects should be designed to coordinate and collaborate with other CDC-supported mechanisms that can cover participant costs.
What type of funding mechanism is this?
This is a cooperative agreement, which typically involves substantial CDC involvement in program planning, technical direction, and/or coordination compared to a standard grant.
What is the funding opportunity number and CFDA listing?
The funding opportunity number is CDC RFA GH12-1230, under CFDA 93.067 (Global AIDS).
How many awards were anticipated, and what was the estimated total funding?
Up to 10 awards were anticipated, with an estimated total funding amount of $45,000,000.
What was the expected award size for individual recipients?
Individual awards were expected to range from $100,000 (floor) to $500,000 (ceiling).
Is cost-sharing or matching required?
No cost-sharing or matching requirement is stated for this opportunity.
Who is eligible to apply?
Eligibility is broad and includes nonprofits (with or without 501(c)(3) status), for-profit organizations (including small, minority-, and women-owned businesses), universities and colleges, research institutions, hospitals, community-based and faith-based organizations, tribal governments and tribal health-related entities, and state and local governments (or their bona fide agents). The listing also explicitly includes non-domestic (non-U.S.) entities.
Are non-U.S. (non-domestic) entities eligible to apply?
Yes. The eligibility list explicitly includes non-domestic (non-U.S.) entities, which is relevant for organizations operating in Nigeria or working with Nigerian partners.
What documentation is required if applying as a bona fide agent of a state or local government?
A binding legal agreement documenting bona fide agent status is required as part of the application package.
Which agency is administering this opportunity?
The administering agency is the Centers for Disease Control and Prevention (CDC).
Who is listed as the contact point for technical issues accessing the announcement?
The CDC Procurement and Grants Office is listed as a contact point for technical issues accessing the announcement.
Is this a current funding opportunity or an archived one?
The timeline provided indicates it is an archived opportunity rather than a currently open competition. It was posted January 25, 2012, had a closing date of April 4, 2012, and an archive date of May 4, 2012.
How should applicants think about sustainability in this opportunity?
Sustainability is the central goal. The opportunity is framed as helping Nigerian organizations build durable internal systems, staff capacity, governance, and management practices so they can consistently manage HIV prevention, care, and treatment programs over time, even as staffing and funding conditions change.
How does this opportunity fit within PEPFAR programming?
This is a CDC cooperative agreement under PEPFAR focused on strengthening local organizational capacity to oversee and manage HIV/AIDS programs, especially those tied to clinical services, laboratories, and strategic information, rather than paying for direct service delivery.
Browse more business programs for HIV and AIDS support
Browse more opportunities from the same agency: Centers for Disease Control and Prevention
Browse more opportunities from the same category: Health
Next opportunity: Implementing Evidence Based Prevention Interventions to Prevent New HIV Infections in the United Republic of Tanzania Under the Presidents Emergency Plan for AIDS Relief (PEPFAR)
Previous opportunity: National Coastal Wetland Conservation Grant Program
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA GH12 1230
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA GH12 1230) also looked into and applied for these:
| Funding Opportunity |
|---|
| Implementing Evidence Based Prevention Interventions to Prevent New HIV Infections in the United Republic of Tanzania Under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH12 1236 Funding Number: CDC RFA GH12 1236 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $540,000 |
| Interventions to Improve HIV/AIDS and Alcohol Related Outcomes (U01) Apply for RFA AA 12 009 Funding Number: RFA AA 12 009 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Competing Revisions for Macromolecular Interactions in Cells (R01) Apply for RFA GM 13 003 Funding Number: RFA GM 13 003 Agency: National Institutes of Health Category: Health Funding Amount: $80,000 |
| USAID/Uganda Therapeutic and Supplementary Products for Improved Nutrition (TASPIN) Apply for RFA 617 12 000002 Funding Number: RFA 617 12 000002 Agency: Uganda USAID Kampala Category: Health Funding Amount: $22,000,000 |
| Rapid Response to Requests for Rural Data Analysis and Issue Specific Rural Research Studies Apply for HRSA 12 090 Funding Number: HRSA 12 090 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Information Services to Rural Hospital Flexibility Grantees Program Cooperative Agreement (Technical Assistance Center) Apply for HRSA 12 098 Funding Number: HRSA 12 098 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Leadership Group for a Clinical Research Network on Vaccines to Prevent HIV infection (UM1) Apply for RFA AI 12 012 Funding Number: RFA AI 12 012 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Claude D. Pepper Older Americans Independence Centers (OAICs) and Coordinating Center (P30) Apply for RFA AG 13 002 Funding Number: RFA AG 13 002 Agency: National Institutes of Health Category: Health Funding Amount: $175,000 |
| NIBIB Research Education Programs for Residents and Clinical Fellows (R25) Apply for PAR 12 085 Funding Number: PAR 12 085 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Support For HIV/AIDS Population Based Surveys And Statistical Capacity Building In Zambia Apply for CDC RFA GH12 1246 Funding Number: CDC RFA GH12 1246 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $2,000,000 |
| Strengthening Laboratory Infrastructure, Quality of Laboratory Services, and Strategic Information Capacity in the Federal Democratic Republic of Ethiopia under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH12 1219 Funding Number: CDC RFA GH12 1219 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $3,276,624 |
| Support Uganda Ministry of Health Capacity to Address HIV and Other Health Priority Conditions through Strengthening Health Systems Under the Presidents Emergency Plan for AIDs Relief Apply for CDC RFA GH12 1216 Funding Number: CDC RFA GH12 1216 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $3,586,824 |
| Expanding Participation of People with Disabilities Apply for RFA 176 12 000003 Funding Number: RFA 176 12 000003 Agency: Kazakhstan USAID Almaty Category: Health Funding Amount: $600,000 |
| Medical Monitoring Project Apply for CDC RFA PS09 93704CONT12 Funding Number: CDC RFA PS09 93704CONT12 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Marketing Innovation For Health Apply for RFA 388 12 000001 Funding Number: RFA 388 12 000001 Agency: Bangladesh USAID Dhaka Category: Health Funding Amount: $15,000,000 |
| Limited Competition for Continuation of the NIH Exploratory Trials in Parkinsons Disease (NET PD) Coordinating and Statistical Centers (U01) Apply for RFA NS 13 001 Funding Number: RFA NS 13 001 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Limited Competition for Continuation of the NIH Exploratory Trials in Parkinsons Disease (NET PD) Clinical Sites (U10) Apply for RFA NS 13 002 Funding Number: RFA NS 13 002 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Resource support for Consortiums for HIV/AIDS and Alcohol Related Outcomes Research Trials (CHAART) U24 Apply for RFA AA 12 010 Funding Number: RFA AA 12 010 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| Strengthening Federal Coordination and Monitoring and Evaluation of the Multi Sectoral response to HIV/AIDS in Ethiopia under the Presidents Emergency Plan for AIDS Relief (PEPFAR). Apply for CDC RFA GH12 1220 Funding Number: CDC RFA GH12 1220 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $1,050,000 |
| HIV Vaccine Research and Design (HIVRAD) Program (P01) Apply for PAR 12 087 Funding Number: PAR 12 087 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA GH12 1230", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.